NLSCX
Price
$18.77
Change
+$0.01 (+0.05%)
Updated
Dec 26 closing price
Net Assets
7.96B
WPOPX
Price
$13.04
Change
-$0.03 (-0.23%)
Updated
Dec 26 closing price
Net Assets
359.16M
Interact to see
Advertisement

NLSCX vs WPOPX

Header iconNLSCX vs WPOPX Comparison
Open Charts NLSCX vs WPOPXBanner chart's image
Neuberger Berman Long Short C
Price$18.77
Change+$0.01 (+0.05%)
VolumeN/A
Net Assets7.96B
Weitz Partners III Opportunity Instl
Price$13.04
Change-$0.03 (-0.23%)
VolumeN/A
Net Assets359.16M
NLSCX vs WPOPX Comparison Chart in %
View a ticker or compare two or three
VS
NLSCX vs. WPOPX commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NLSCX is a Hold and WPOPX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NLSCX has more cash in the bank: 7.96B vs. WPOPX (359M). WPOPX pays higher dividends than NLSCX: WPOPX (0.02) vs NLSCX (0.00). NLSCX was incepted earlier than WPOPX: NLSCX (14 years) vs WPOPX (20 years). NLSCX (2.43) is less costly to investors than WPOPX (1.18). NLSCX is a more actively managed with annual turnover of: 48.00 vs. WPOPX (25.00). NLSCX has a lower initial minimum investment than WPOPX: NLSCX (1000) vs WPOPX (1000000). NLSCX annual gain was more profitable for investors over the last year : 5.21 vs. WPOPX (-3.12). NLSCX return over 5 years is better than : 16.51 vs. WPOPX (-14.17).
NLSCXWPOPXNLSCX / WPOPX
Total Expense Ratio2.431.18206%
Annual Report Gross Expense Ratio2.431.18206%
Fund Existence14 years20 years-
Gain YTD6.105-1.659-368%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets7.96B359M2,218%
Annual Yield % from dividends0.000.02-
Returns for 1 year5.21-3.12-167%
Returns for 3 years25.7618.90136%
Returns for 5 years16.51-14.17-117%
Returns for 10 years45.61-4.22-1,081%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BFGBX43.280.01
+0.02%
BlackRock Capital Appreciation K
VPMCX180.67N/A
N/A
Vanguard PRIMECAP Inv
MXMVX14.66N/A
N/A
Empower Mid Cap Value Inv
GRGRX46.89-0.01
-0.02%
Goldman Sachs Equity Income R
RYOIX76.19-0.43
-0.56%
Rydex Biotechnology Inv